Blog
PRIMR Work Culture: Core Values

By: David Grew MD MPH
"Welcoming new hires who resonate with these values ensures our collective dedication to making a meaningful impact in the industry."
∗ ∗ ∗
As our startup expands this year, we will share our core values with every team member. With a focus on patient centricity, a preference for simplicity, and "Fail fast, iterate" mentality, our culture emphasizes a commitment to improving healthcare experiences, streamlined processes, and an innovative, adaptive mindset. Welcoming new hires who resonate with these values ensures our collective dedication to making a meaningful impact in the industry.
Here are PRIMR’s core values and why they drive our business forward:
We work for the patient.
- Our accumulated experience and knowledge are based on feedback from real patients with real problems sharing a
- their lived experiences.
- Patients teach which parts of medical treatments are hard to understand.
- Patients teach us which explanations and visuals make complex medical concepts and treatments easier to understand.
- The knowledge we gain from patients compounds over time and we harness this to improve our products.
- We exist to transform the intimacy and magic of a curated doctor-patient explanation into a scalable asset.
Simplicity is king.
- When an explanation is complex the explainer doesn’t fully understand the problem.
- We believe any patient can understand any medical problem and corresponding treatment.
- When complex problems are broken down into basic principles, the world of potential solutions is narrower and more intuitively obvious to the audience.
Fanatical attention to detail.
- Everything we create must be medically accurate.
- We must find a balance between simplicity and medical accuracy.
- Attention to detail means extreme precision, not excessive information.
- We need to thread the needle on keeping things simple and relatable for patients but medically precise to maintain trust and credibility with physician peers.
Make it look attractive.
- Even a sketch on a clinic exam table paper can be attractive.
- We use clean lines, black and white with primary colors to avoid distracting our audience from the core medical message.
- We avoid flashy graphics which can be a crutch against the inability to stand on your clear thinking.
We are scrappy.
- We come from grassroots, based on actual conversations between doctors and patients.
- We do not have venture capital backing, we are self-funded.
- We are a lean, nimble, global team with extreme talent diversity - this is an unfair advantage we enjoy.
- We are frugal in our spending and prioritize only the highest-leverage projects by the 80/20 principle.
- We aim to turn a profit to ensure our long-term financial viability and expand the number of patient lives we can impact.
Fail fast, iterate.
- We learn more from our failures than our successes.
- We are precise, and we do not callously or flippantly risk failure when it involves patients. But we recognize failures with clear eyes and rapidly iterate to change our process accordingly.
- The fastest way to optimize the impact of our content and its distribution is by taking calculated risks, and rapidly pivoting off failed strategies.
Accountability.
- Each team member is responsible for executing their role.
- When we make a mistake, we own it and explain what we did wrong, and how we’ll avoid it going forward.
- Accountability also means owning your wins. While we celebrate as a team, we call out specific team members whose efforts made an outsized impact on the outcome.
Compound by adding value.
- We harvest exponential growth by constantly seeking ways to add value to our customers. We ask, “How can we make this solve more of their problems?”
- We are patient with growth outcomes and reject a desperate “growth at all costs” philosophy. Instead, we believe the growth outcome takes care of itself when we “provide customer value at all costs.”
- We achieve non-linear growth by having repeat customers, in addition to steady new customer growth.
Other Posts

AMPLIFY Trial: Advancing Imaging for Prostate Cancer Recurrence
In this blog, we explore how the AMPLIFY trial is testing a new PSMA PET tracer to detect prostate cancer recurrence earlier and more accurately, helping doctors guide more personalized treatment for patients with rising PSA levels.
Read more

A New Direction for Lung NETs: Exploring the Alliance Study and Lutetium Therapy
This study compares everolimus to a targeted radiation therapy called Lutetium 177 Dotatate for patients with advanced lung NETs. In this blog, we explore how the trial could lead to more effective, better-tolerated treatment options for this rare cancer.
Read more

The CLARIFY Trial: Advancing Imaging for High-Risk Prostate Cancer
The CLARIFY trial is testing a new imaging agent, 64Cu-SAR-bisPSMA, to improve prostate cancer detection. With better sensitivity and a longer imaging window, it aims to provide clearer scans, enabling more accurate staging and personalized treatment plans.
Read more